About 6 results found for searched term "50-63-5" (0.055 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M2510 | Chloroquine diphosphate | Autophagy |
| Chloroquine Phosphate | ||
| Chloroquine diphosphate is a 4-aminoquinoline anti-malarial and anti-rheumatoid agent. | ||
| M6213 | 6-Maleimidohexanoic acid N-hydroxysuccinimide ester | ADC Linker |
| EMCS | ||
| 6-Maleimidohexanoic acid N-hydroxysuccinimide ester(ECMS) is a useful protective group in antibody drug conjugates. | ||
| M13904 | Angiotensin (1-7) (acetate) | Angiotensin Receptor |
| Ang-(1-7) (acetate) | ||
| Angiotensin 1-7 (Ang-(1-7)) acetate is an endogenous heptapeptide from the renin-angiotensin system (RAS) with a cardioprotective role due to its anti-inflammatory and anti-fibrotic activities in cardiac cells. | ||
| M14861 | Thalidomide-O-amido-C8-NH2 TFA | PROTAC |
| Cereblon Ligand -Linker Conjugates 2 TFA; E3 Ligase Ligand-Linker Conjugates 20 TFA | ||
| Thalidomide-O-amido-C8-NH2 TFA (Cereblon Ligand -Linker Conjugates 2 TFA) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. | ||
| M17596 | Leeaoside | Sesquiterpenoids |
| Leeaoside | ||
| M30694 | RSM-932A | Others |
| TCD-717 | ||
| RSM-932A (TCD-717) is a specific ChoKα inhibitor with IC50s of 1 and 33 μM for human recombinant ChoKα and ChoKβ enzymes, respectively. RSM-932A acts as the “first in humans” compound targeting ChoKα. RSM-932A is potent in vitro anti-proliferative and in vivo anti-tumoral activity against human xenografts in mice, showing high efficacy with low toxicity profiles. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
